# SPECTRUM PHARMACEUTICALS INC

SPECTRUM PHARMACEUTICALS INC is a company headquartered in Henderson, NV, United States.

## Company overview

- **Legal name:** SPECTRUM PHARMACEUTICALS INC
- **Former names in filing history:** NEOTHERAPEUTICS INC (1996-11-12 to 2002-12-11)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Henderson, NV, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000831547

## About

SPECTRUM PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000831547, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-31, it reported annual revenue of USD 10,114,000; net income of USD -75,401,000; total assets of USD 103,338,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $10.1M (USD 10,114,000)
- **Net income:** -$75.4M (USD -75,401,000)
- **Total assets:** $103.3M (USD 103,338,000)
- **Cash and equivalents:** $40.4M (USD 40,368,000)
- **Operating cash flow:** -$97.0M (USD -96,989,000)

### FY2021 (period ended 2021-12-31)

- **Net income:** -$158.6M (USD -158,628,000)
- **Total assets:** $111.5M (USD 111,548,000)
- **Cash and equivalents:** $88.5M (USD 88,539,000)
- **Operating cash flow:** -$119.5M (USD -119,486,000)

### FY2020 (period ended 2020-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$160.9M (USD -160,868,000)
- **Total assets:** $196.8M (USD 196,798,000)
- **Cash and equivalents:** $46.0M (USD 46,009,000)
- **Operating cash flow:** -$121.6M (USD -121,629,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$112.7M (USD -112,689,000)
- **Total assets:** $263.4M (USD 263,433,000)
- **Cash and equivalents:** $64.4M (USD 64,418,000)
- **Operating cash flow:** -$134.6M (USD -134,631,000)

## Recent SEC filings

- Form 8-K — filed 2023-08-01 — period 2023-07-31 — 8-K
- Form 8-K — filed 2023-07-27 — period 2023-07-27 — 8-K
- Form 8-K — filed 2023-05-17 — period 2023-05-16 — 8-K
- Form 10-Q — filed 2023-05-11 — period 2023-03-31 — 10-Q
- Form 8-K — filed 2023-05-09 — period 2023-05-09 — 8-K
- Form 8-K — filed 2023-05-01 — period 2023-04-25 — 8-K
- Form 10-K/A — filed 2023-05-01 — period 2022-12-31 — 10-K/A
- Form 8-K — filed 2023-04-25 — period 2023-04-24 — FORM 8-K
- Form 8-K — filed 2023-04-04 — period 2023-03-30 — 8-K
- Form 8-K — filed 2023-04-03 — period 2023-04-01 — 8-K
- Form 10-K — filed 2023-03-31 — period 2022-12-31 — 10-K
- Form 8-K — filed 2023-03-22 — period 2023-03-22 — 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/spectrum-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology